Our Science
About Us
News & Publications
Partnerships
Contact Us
Join Us
News & Publications
our latest breakthroughs
Our platform, which combines oncRNA technology with AI, provides actionable insights into cancer biology.
Featured
Exai Bio’s RNA-based Liquid Biopsy Platform Delivers Promising Data on Detecting Breast Cancer at its Earliest Stages
Read More >
News & Press
follow us
into the future.
Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Jun 2023
Exai Bio Presents New Non-Small Cell Lung Cancer Early Detection Data at the American Association for Cancer Research (AACR) 2023 Annual Meeting
Apr 2023
Exai Bio and Quantum Leap Healthcare Collaborative Announce Expanded Participation in I-SPY 2 Trial to Advance Exai’s Novel RNA-based Liquid Biopsy Platform in Breast Cancer
Mar 2023
Exai Bio Announces Appointments of Emi Zychlinsky and Seema Singh Bhan to its Executive Leadership Team
Feb 2023
Exai Bio’s RNA-based Liquid Biopsy Platform Delivers Promising Data on Detecting Breast Cancer at its Earliest Stages
Dec 2022
Exai Bio Presents Data Demonstrating that its Novel RNA-based Liquid Biopsy Platform has Potential for Early Detection and Monitoring of Colorectal Cancer
Sep 2022
How oncRNA Technology Could Revolutionize Cancer Diagnostics
Sep 2022
Exai Bio Commercializing Noncoding RNA Method for Liquid Biopsy Applications
Apr 2022
Exai Bio Demonstrates its Unique RNA-based Liquid Biopsy Strategy for Early Detection and Monitoring of Multiple Cancers
Apr 2022
Exai Bio Secures $67.5 Million Series A
Dec 2021
stay up-to-date
Thank you for your interest!
Oops! Something went wrong. Please try again later.
Publications & Presentations
science driven,
patient focused.
ASCO 2023
Detection of early-stage cancers using circulating orphan non-coding RNAs in blood
Jun 2023
BOG 2023
Transcriptome-wide co-expression of small non-coding RNAs and genes in cancer
May 2023
AACR 2023
Blood-based Early Detection of Non-small cell Lung Cancer using Orphan Noncoding RNAs
Apr 2023
SABCS 2022
Early Stage Breast Cancer Detection using Orphan Non-coding RNAs
Dec 2022
ESMO 2022
Serum-Based Colorectal Cancer Detection using OncRNAs
Sep 2022
AACR 2022
Discovery and Validation of Orphan Noncoding RNA Profiles across Multiple Cancers in TCGA and Two Independent Cohorts
Apr 2022
SABCS 2021
Tumor-Released Circulating Orphan Noncoding RNAs Reflect Treatment Response and Survival in Breast Cancer
Dec 2021
Nature Medicine
Cancer Cells Exploit an Orphan RNA to Drive Metastatic Progression
Nov 2018
Keep Reading
ESMO 2022
Serum-Based Colorectal Cancer Detection using OncRNAs
Sep 2022
AACR 2022
Discovery and Validation of Orphan Noncoding RNA Profiles across Multiple Cancers in TCGA and Two Independent Cohorts
Apr 2022
SABCS 2021
Tumor-Released Circulating Orphan Noncoding RNAs Reflect Treatment Response and Survival in Breast Cancer
Dec 2021
Nature Medicine
Cancer Cells Exploit an Orphan RNA to Drive Metastatic Progression
Nov 2018
>
interested in collaborating?
reach out to us.
contact us
Close the cookie popup
Cookie Settings
By clicking "Accept All", you are agreeing to store cookies on your device to enhance your experience and help Exai's marketing.
Accept All
cookie settings
Close the cookie popup
Cookie Settings
By clicking "Accept All", you are agreeing to store cookies on your device to enhance your experience and help Exai's marketing.
More info
.
Strictly Necessary
Required in order to enable all basic site functionality.
Personalization
Allows the site to remember choices that you make.
Analytics
Helps Exai better understand how the site performs.
Marketing
Used to deliver advertising that's more relevant to you.
Accept All
save settings